Anzeige
Mehr »
Login
Montag, 20.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
GOLD-MINEN vor Jahrhundert-Hausse?! Diese Aktie sofort kaufen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JLYP | ISIN: KYG211081248 | Ticker-Symbol: 2M7C
Frankfurt
17.05.24
10:30 Uhr
0,805 Euro
+0,005
+0,62 %
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
CHINA MEDICAL SYSTEM HOLDINGS LTD Chart 1 Jahr
5-Tage-Chart
CHINA MEDICAL SYSTEM HOLDINGS LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,8250,87019.05.
0,8100,88517.05.

Aktuelle News zur CHINA MEDICAL SYSTEM Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
13.05.Dividendenbekanntmachungen (13.05.2024)5.880 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  ADECOAGRO SA  LU0584671464  0,1682 USD  0,1561 EUR  ADVANSIX INC  US00773T1016  0,16 USD  0,1485 EUR  AMERICAN WATER WORKS COMPANY INC  US0304201033  0...
► Artikel lesen
09.05.CMS (00867): FOURTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION1
09.05.CMS (00867): ANNOUNCEMENT ON VOTING RESULTS OF ANNUAL GENERAL MEETING HELD ON 9 MAY 2024-
23.04.China Medical System Holdings Ltd.: New Drug Application of Desidustat Tablets Accepted in China96SHENZHEN, CHINA, April 23, 2024 (GLOBE NEWSWIRE) -- Desidustat Tablets are novel, oral HIF-PHI for treating anaemia in non-dialysis adult chronic kidney disease patients. The Product is administrated...
► Artikel lesen
23.04.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT NEW DRUG APPLICATION OF DESIDUSTAT TABLETS ACCEPTED IN CHINA-
17.04.CMS (00867): NEXT DAY DISCLOSURE RETURN1
17.04.CMS (00867): NOTIFICATION LETTER1
17.04.CMS (00867): FORM OF PROXY-
17.04.CMS (00867): NOTICE OF ANNUAL GENERAL MEETING1
17.04.CMS (00867): PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS, DECLARATION OF FINAL DIVIDEND, GENERAL MANDATES TO ISSUE SHARES AND TO REPURCHASE SHARES, ...-
17.04.CMS (00867): ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2023-
17.04.CMS (00867): ANNUAL REPORT 2023-
16.04.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT NEW DRUG APPLICATION OF RUXOLITINIB CREAM APPROVED IN MACAU-
10.04.CMS (00867): NEXT DAY DISCLOSURE RETURN1
02.04.CMS (00867): NEXT DAY DISCLOSURE RETURN1
01.04.China Medical System Holdings Ltd.: CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia204Povorcitinib, a selective oral JAK1 inhibitor discovered by Incyte, is an investigational medicine being evaluated for the treatment of non-segmental vitiligo, hidradenitis suppurativa (HS), prurigo...
► Artikel lesen
28.03.China Medical System Holdings Limited reports FY results7
28.03.China Medical System Holdings Ltd.: China Medical System (867.HK)2023 Annual Results: Despite of the Temporary Financial Performance Pressure Fresh Catalysts Emerged from Successive Innovation Breakthroughs144SHENZHEN, CHINA, March 27, 2024 (GLOBE NEWSWIRE) -- On March 27, 2024, China Medical System ("CMS" or the "Company") released its 2023 annual results. The Company recorded a turnover of RMB8,013 million...
► Artikel lesen
27.03.CMS (00867): VOLUNTARY ANNOUNCEMENT ADOPTION OF SHARE AWARD SCHEMES RELATED TO CMS NEW PRODUCTS1
27.03.CMS (00867): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 20234
Seite:  Weiter >>
33 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1